Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

The model can effectively test gene functions and drug responses in human skin.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Low dose methotrexate does not increase hair fall and may reduce it.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.